196 related articles for article (PubMed ID: 8116226)
1. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.
Danon AD; Krishnan J; Frizzera G
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):369-82. PubMed ID: 8116226
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature.
Pina-Oviedo S; Miranda RN; Lin P; Manning JT; Medeiros LJ
Hum Pathol; 2017 Oct; 68():136-146. PubMed ID: 28873356
[TBL] [Abstract][Full Text] [Related]
4. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants.
Nguyen DT; Diamond LW; Hansmann ML; Alavaikko MJ; Schröder H; Fellbaum C; Fischer R
Histopathology; 1994 May; 24(5):437-43. PubMed ID: 8088715
[TBL] [Abstract][Full Text] [Related]
5. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.
Lin O; Frizzera G
Am J Surg Pathol; 1997 Nov; 21(11):1295-306. PubMed ID: 9351567
[TBL] [Abstract][Full Text] [Related]
6. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.
Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D
Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293
[TBL] [Abstract][Full Text] [Related]
7. "Follicular variant" of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.
Kojima M; Shimizu K; Ikota H; Ohno Y; Motoori T; Itoh H; Masawa N; Nakamura S
J Clin Exp Hematop; 2008 Nov; 48(2):39-45. PubMed ID: 19039195
[TBL] [Abstract][Full Text] [Related]
8. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
[TBL] [Abstract][Full Text] [Related]
9. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient.
Katano H; Kaneko K; Shimizu S; Saito T; Irié T; Mori S
Pathol Int; 1997 Oct; 47(10):703-6. PubMed ID: 9361105
[TBL] [Abstract][Full Text] [Related]
11. Castleman's disease.
Palestro G; Turrini F; Pagano M; Chiusa L
Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
[TBL] [Abstract][Full Text] [Related]
12. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease.
Chan JK; Tsang WY; Ng CS
Am J Surg Pathol; 1994 May; 18(5):517-25. PubMed ID: 8172326
[TBL] [Abstract][Full Text] [Related]
13. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells.
Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD
Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957
[TBL] [Abstract][Full Text] [Related]
14. Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman's disease.
Kojima M; Nakamura S; Miyawaki S; Ohno Y; Sakata N; Masawa N
APMIS; 2005 Apr; 113(4):288-95. PubMed ID: 15865611
[TBL] [Abstract][Full Text] [Related]
15. [Stroma-rich variant of hyaline-vascular Castleman's disease: a clinicopathologic and histogenetic study].
Xiong Y; Zhang Y; Wang Y; Na J; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):14-8. PubMed ID: 20388393
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease.
Peh SC; Shaminie J; Poppema S; Kim LH
Singapore Med J; 2003 Apr; 44(4):185-91. PubMed ID: 12952030
[TBL] [Abstract][Full Text] [Related]
17. Primary hyaline vascular Castleman disease of the kidney: case report and literature review.
Li Y; Zhao H; Su B; Yang C; Li S; Fu W
Diagn Pathol; 2019 Aug; 14(1):94. PubMed ID: 31439011
[TBL] [Abstract][Full Text] [Related]
18. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.
Amin HM; Medeiros LJ; Manning JT; Jones D
Am J Surg Pathol; 2003 Jan; 27(1):91-100. PubMed ID: 12502931
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
20. Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman's disease of hyaline-vascular type.
Izumi M; Mochizuki M; Kuroda M; Iwaya K; Mukai K
Virchows Arch; 2002 Oct; 441(4):400-5. PubMed ID: 12404066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]